4//SEC Filing
te Boekhorst Paul Francis Olivier 4
Accession 0001437749-25-034257
CIK 0000811641other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 8:43 AM ET
Size
5.5 KB
Accession
0001437749-25-034257
Insider Transaction Report
Form 4
te Boekhorst Paul Francis Olivier
DirectorPresident and CEO
Transactions
- Award
Stock Options (right to buy)
2025-11-07$6.10/sh+74,277$453,090→ 150,260 totalExercise: $6.10Exp: 2035-11-07→ Common Stock (74,277 underlying)
Footnotes (1)
- [F1]Option grant made to Mr. te Boekhorst in connection with his commencement of employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 24,759 options on the first, second, and third anniversary of the grant date.
Documents
Issuer
IMMUCELL CORP /DE/
CIK 0000811641
Entity typeother
Related Parties
1- filerCIK 0002095704
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 8:43 AM ET
- Size
- 5.5 KB